but considered rare in another due to low prevalence of the disease in that region. Currently, there are between 6000 and 8000 known rare diseases and around five new rare diseases are described in medical literature each week. In the EU, as many as 30 million people may be affected by one of over 6000 existing rare diseases [7, 8] . HIV/AIDS and Influenza A (H1N1) are examples of the most recent destructive global pandemics in history.
Recently, Public Health England (PHE) reported investigating an increase in cases of rare disease, particularly acute flaccid paralysis. So far in 2018, 28 cases have been reported to PHE. A rise has also been reported in the US. This disease has since been eradicated in Britain, the US, Australia and most part of Europe since 1988, with the advent of Sabin's OPV vaccine in 1962 [9] . In addition, there has been an increase in zoonotic diseases, with the re-emergence of Lassa fever, first being reported in Nigeria and subsequently spreading across most parts of West Africa. Cases have been reported in some European countries such as Germany and Sweden. The risk of disease spreading to non-endemic countries by travellers from Lassa fever endemic countries in West Africa is very low. Widespread trade in animal husbandry among countries has also seen the rise in imported infections [10] .
However, only a few studies have emphasised increasing frequency and changes in patterns of imported infections carried by travellers and related implications for the region, particularly in children [11] [12] [13] . A prospective study done by Andrew et al. with 58 children showed that the more common infections were malaria, traveller's diarrhoea and hepatitis [13] . The travel history of patients with focus on the geographical area during the clinical history taking procedure is very significant in patient management and has wider implications for public health. The importance of travel history is reflected by British guidelines on the management and control of viral haemorrhagic fevers [14] , which heavily rely on epidemiological evidence. Similar risk assessment algorithms should be employed regarding emerging infections in this current climate of changing disease transmission patterns, in order to understand the cause and predict the future impacts of these changes on the health of children.
Finally, healthcare workers are more likely to see an increasingly number of cases of rare and imported infections due to intercontinental travel, as well as human and environmental displacement. The principle aim of this special issue is to enhance a collaborative effort to share good practices amongst health care providers, especially in relation to uncommon and rare infections in children, as well as to provide evidence-based practice for learning and educational development, particularly of frontline health care professionals. This will undoubtedly include increased active surveillance activities, studies to elucidate the modes of indigenous transmission, and preventive measures.
Conflicts of Interest:
The author declares no conflict of interest.
